Opendata, web and dolomites

MYA

MYA, the innovative diagnostics platform for the full mapping of personal allergies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MYA project word cloud

Explore the words cloud of the MYA project. It provides you a very rough idea of what is the project "MYA" about.

created    provision    made    days    patients    extreme    costly    international    immunoglobulin    immune    caused    saturated    allergy    life    risk    quality    public    healthcare    profile    treatment    screening    alltox    personal    food    serve    diagnosis    worldwide    launch       advice    revenues    specialists    either    efficiency    time    disease    million    ready    ige    allergen    detect    run    collect    mya    primary    selling    inhalant    saved    full    inadequate    500    reducing    map    market    limited    weeks    network    self    patient    pharmacies    contact    quantitatively    plex    420    scarcity    benefits    treatments    prescribe    entails    agree    personalized    relieve    150    array    report    price    cumulative    website    chronic    care    centres    allergies    detection    units    individuals    accessible    society    suffering    conveniently    diagnostic    ship    allergens    gets    proper    affordable    laboratories    population    turn    incurred   

Project "MYA" data sheet

The following table provides information about the project.

Coordinator
ALLTOX S.R.L. 

Organization address
address: VIA SARDEGNA 38
city: MILANO
postcode: 20146
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.alltox.it/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLTOX S.R.L. IT (MILANO) coordinator 50˙000.00

Map

 Project objective

Allergies are chronic conditions caused by an extreme immune response to inhalant and food allergens that affect today 500 million (M) individuals worldwide and 150 M in Europe. International institutions all agree in the benefits that early allergy diagnosis and targeted treatment could bring to society. However, only 5% of the population gets a proper diagnosis, either due to limited awareness or scarcity of allergy specialists. Thus, patients try to self-manage their condition and non-specialists prescribe inadequate treatments. Therefore, the patient’s quality of life could be improved if allergy diagnosis were made accessible to the general public. Also, € 30 M/year would be saved in Europe by enhancing the efficiency of our healthcare system. In response, ALLTOX has created MYA (Map Your Allergies), a high quality, cost-effective test for allergy screening. Our 40-plex array-based technology will serve to quantitatively detect the patient’s immunoglobulin IgE, which are produced by the immune system upon contact with a particular allergen. The personal allergy profile can be obtained and thus, facilitate an adequate management. MYA will be offered to the general public at an affordable price through a network of pharmacies and primary care centres, who will collect the sample and ship it to our selected laboratories to run the analysis. In only 3 days, a full report and personalized advice will be conveniently available to the patient through our website, greatly reducing the current time-to-diagnosis (8 weeks). Our product entails a cost-effective diagnostic test that will facilitate detection of allergy risk and provision of adequate management to those patients suffering from this chronic disease. Also, the MYA test will help to relieve the costly impact incurred by allergies on our ready saturated healthcare system. In turn, MYA will provide ALLTOX estimated cumulative revenues of €40.2 M after selling 420 000 units within five years from market launch.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MYA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MYA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More